| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Omega Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 110,000 | 22 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OMGAQ | Omega Therapeutics, Inc. | 22 Nov 2024 | 1 | $0 | 4 | Chief Scientific Officer | 26 Nov 2024, 18:31 |
| OMGAQ | Omega Therapeutics, Inc. | 22 Nov 2024 | 0 | $0 | 3 | Chief Scientific Officer | 26 Nov 2024, 18:27 |